CN102879343B - 用多波长吸收单通道同步测量多种酶活性的方法 - Google Patents
用多波长吸收单通道同步测量多种酶活性的方法 Download PDFInfo
- Publication number
- CN102879343B CN102879343B CN201210355606.8A CN201210355606A CN102879343B CN 102879343 B CN102879343 B CN 102879343B CN 201210355606 A CN201210355606 A CN 201210355606A CN 102879343 B CN102879343 B CN 102879343B
- Authority
- CN
- China
- Prior art keywords
- colour developing
- chromogenic substrate
- enzyme
- product
- wavelength
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 371
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 371
- 238000000034 method Methods 0.000 title claims abstract description 119
- 230000000694 effects Effects 0.000 title claims abstract description 115
- 239000003593 chromogenic compound Substances 0.000 claims abstract description 516
- 238000010521 absorption reaction Methods 0.000 claims abstract description 360
- 230000002255 enzymatic effect Effects 0.000 claims abstract description 79
- 238000004458 analytical method Methods 0.000 claims abstract description 50
- 238000006911 enzymatic reaction Methods 0.000 claims abstract description 22
- 238000000862 absorption spectrum Methods 0.000 claims abstract description 21
- 230000010354 integration Effects 0.000 claims abstract description 21
- 238000003672 processing method Methods 0.000 claims abstract description 16
- 238000012216 screening Methods 0.000 claims abstract description 14
- 230000009102 absorption Effects 0.000 claims description 359
- 238000006243 chemical reaction Methods 0.000 claims description 195
- 230000008859 change Effects 0.000 claims description 137
- 230000008033 biological extinction Effects 0.000 claims description 79
- 238000012937 correction Methods 0.000 claims description 65
- 239000000758 substrate Substances 0.000 claims description 48
- 230000001915 proofreading effect Effects 0.000 claims description 39
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 37
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 claims description 26
- -1 4-nitro-1-naphthyl Chemical group 0.000 claims description 24
- 238000006460 hydrolysis reaction Methods 0.000 claims description 24
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 claims description 22
- 230000001360 synchronised effect Effects 0.000 claims description 22
- 238000005259 measurement Methods 0.000 claims description 20
- 230000004044 response Effects 0.000 claims description 20
- 230000008878 coupling Effects 0.000 claims description 19
- 238000010168 coupling process Methods 0.000 claims description 19
- 238000005859 coupling reaction Methods 0.000 claims description 19
- AUIRNGLMBHIITH-UHFFFAOYSA-N 4-nitronaphthalen-1-ol Chemical class C1=CC=C2C(O)=CC=C([N+]([O-])=O)C2=C1 AUIRNGLMBHIITH-UHFFFAOYSA-N 0.000 claims description 17
- 230000007062 hydrolysis Effects 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 16
- 230000000996 additive effect Effects 0.000 claims description 15
- 238000004140 cleaning Methods 0.000 claims description 15
- 125000002642 gamma-glutamyl group Chemical group 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 11
- RQQFEJKTXYWTAZ-UHFFFAOYSA-N (4-nitronaphthalen-1-yl) dihydrogen phosphate Chemical compound C1=CC=C2C(OP(O)(=O)O)=CC=C([N+]([O-])=O)C2=C1 RQQFEJKTXYWTAZ-UHFFFAOYSA-N 0.000 claims description 10
- 102000004357 Transferases Human genes 0.000 claims description 10
- 108090000992 Transferases Proteins 0.000 claims description 10
- 229950006238 nadide Drugs 0.000 claims description 10
- 102000005744 Glycoside Hydrolases Human genes 0.000 claims description 9
- 108010031186 Glycoside Hydrolases Proteins 0.000 claims description 9
- 230000002860 competitive effect Effects 0.000 claims description 9
- 102220029901 rs140332992 Human genes 0.000 claims description 9
- 239000000872 buffer Substances 0.000 claims description 8
- 102220052991 rs139591041 Human genes 0.000 claims description 8
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 claims description 7
- 108010082126 Alanine transaminase Proteins 0.000 claims description 7
- 102000003855 L-lactate dehydrogenase Human genes 0.000 claims description 7
- 108700023483 L-lactate dehydrogenases Proteins 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 7
- WMZTYIRRBCGARG-VIFPVBQESA-N (2s)-2-azaniumyl-5-(4-nitroanilino)-5-oxopentanoate Chemical class OC(=O)[C@@H](N)CCC(=O)NC1=CC=C([N+]([O-])=O)C=C1 WMZTYIRRBCGARG-VIFPVBQESA-N 0.000 claims description 6
- ZYMCBJWUWHHVRX-UHFFFAOYSA-N (4-nitrophenyl)-phenylmethanone Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)C1=CC=CC=C1 ZYMCBJWUWHHVRX-UHFFFAOYSA-N 0.000 claims description 6
- 108700023418 Amidases Proteins 0.000 claims description 6
- 108090000371 Esterases Proteins 0.000 claims description 6
- 102000013460 Malate Dehydrogenase Human genes 0.000 claims description 6
- 108010026217 Malate Dehydrogenase Proteins 0.000 claims description 6
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 claims description 6
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims description 6
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims description 6
- 102000005262 Sulfatase Human genes 0.000 claims description 6
- 230000009471 action Effects 0.000 claims description 6
- 102000005922 amidase Human genes 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 108060007951 sulfatase Proteins 0.000 claims description 6
- 230000008030 elimination Effects 0.000 claims description 5
- 238000003379 elimination reaction Methods 0.000 claims description 5
- 230000002401 inhibitory effect Effects 0.000 claims description 5
- 230000003993 interaction Effects 0.000 claims description 5
- 230000035484 reaction time Effects 0.000 claims description 5
- 238000012360 testing method Methods 0.000 claims description 5
- DWPBDZDXURNBJP-UHFFFAOYSA-N P(=O)(O)(O)O.[N+](=O)([O-])C1=CC=C(C=C1)C(C1=CC=CC=C1)=O Chemical compound P(=O)(O)(O)O.[N+](=O)([O-])C1=CC=C(C=C1)C(C1=CC=CC=C1)=O DWPBDZDXURNBJP-UHFFFAOYSA-N 0.000 claims description 4
- 238000013459 approach Methods 0.000 claims description 4
- 230000003301 hydrolyzing effect Effects 0.000 claims description 4
- QRMMKVGWZCSDEC-UHFFFAOYSA-N 2-(2-nitro-5-sulfanylphenyl)acetic acid Chemical compound [N+](=O)([O-])C1=C(C=C(C=C1)S)CC(=O)O QRMMKVGWZCSDEC-UHFFFAOYSA-N 0.000 claims description 3
- ZQKCRZQJMZQAOY-UHFFFAOYSA-N 2-(4-nitronaphthalen-1-yl)acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=C([N+]([O-])=O)C2=C1 ZQKCRZQJMZQAOY-UHFFFAOYSA-N 0.000 claims description 3
- PJKVFARRVXDXAD-UHFFFAOYSA-N 2-naphthaldehyde Chemical compound C1=CC=CC2=CC(C=O)=CC=C21 PJKVFARRVXDXAD-UHFFFAOYSA-N 0.000 claims description 3
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 claims description 3
- TYMLOMAKGOJONV-IDEBNGHGSA-N 4-nitroaniline Chemical class N[13C]1=[13CH][13CH]=[13C]([N+]([O-])=O)[13CH]=[13CH]1 TYMLOMAKGOJONV-IDEBNGHGSA-N 0.000 claims description 3
- AXBVSRMHOPMXBA-UHFFFAOYSA-N 4-nitrothiophenol Chemical compound [O-][N+](=O)C1=CC=C(S)C=C1 AXBVSRMHOPMXBA-UHFFFAOYSA-N 0.000 claims description 3
- GANZODCWZFAEGN-UHFFFAOYSA-N 5-mercapto-2-nitro-benzoic acid Chemical compound OC(=O)C1=CC(S)=CC=C1[N+]([O-])=O GANZODCWZFAEGN-UHFFFAOYSA-N 0.000 claims description 3
- FYEHYMARPSSOBO-UHFFFAOYSA-N Aurin Chemical compound C1=CC(O)=CC=C1C(C=1C=CC(O)=CC=1)=C1C=CC(=O)C=C1 FYEHYMARPSSOBO-UHFFFAOYSA-N 0.000 claims description 3
- ZVNGAODBMHPDDH-UHFFFAOYSA-N C(C)(=O)O.[N+](=O)([O-])C1=CC=C(C=C1)C(C1=CC=CC=C1)=O Chemical class C(C)(=O)O.[N+](=O)([O-])C1=CC=C(C=C1)C(C1=CC=CC=C1)=O ZVNGAODBMHPDDH-UHFFFAOYSA-N 0.000 claims description 3
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims description 3
- 241001597008 Nomeidae Species 0.000 claims description 3
- 238000006555 catalytic reaction Methods 0.000 claims description 3
- 238000012886 linear function Methods 0.000 claims description 3
- 150000005002 naphthylamines Chemical class 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- 238000006722 reduction reaction Methods 0.000 claims description 3
- 102220279556 rs1305090923 Human genes 0.000 claims description 3
- 102220111426 rs140810408 Human genes 0.000 claims description 3
- 102220060030 rs55861249 Human genes 0.000 claims description 3
- 102220134064 rs886055163 Human genes 0.000 claims description 3
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims 3
- XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 claims 3
- 238000009825 accumulation Methods 0.000 claims 2
- 230000002452 interceptive effect Effects 0.000 claims 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 1
- 150000004982 aromatic amines Chemical class 0.000 claims 1
- 238000004364 calculation method Methods 0.000 claims 1
- 238000005457 optimization Methods 0.000 claims 1
- 230000008569 process Effects 0.000 abstract description 18
- 229940125532 enzyme inhibitor Drugs 0.000 abstract description 8
- 239000002532 enzyme inhibitor Substances 0.000 abstract description 8
- 238000005516 engineering process Methods 0.000 abstract description 7
- 238000013461 design Methods 0.000 abstract description 5
- 238000001514 detection method Methods 0.000 abstract description 4
- 238000007689 inspection Methods 0.000 abstract description 4
- 238000002372 labelling Methods 0.000 abstract description 4
- 239000012472 biological sample Substances 0.000 abstract description 2
- 239000003112 inhibitor Substances 0.000 abstract description 2
- 230000031700 light absorption Effects 0.000 abstract description 2
- 238000011160 research Methods 0.000 abstract description 2
- 230000036632 reaction speed Effects 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 349
- 229940088598 enzyme Drugs 0.000 description 255
- 239000000243 solution Substances 0.000 description 59
- 108010005774 beta-Galactosidase Proteins 0.000 description 42
- 239000000523 sample Substances 0.000 description 36
- 102000005936 beta-Galactosidase Human genes 0.000 description 32
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 29
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 28
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 24
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 24
- 238000013016 damping Methods 0.000 description 23
- 239000012530 fluid Substances 0.000 description 23
- 229930182470 glycoside Natural products 0.000 description 21
- 229960001399 clenbuterol hydrochloride Drugs 0.000 description 20
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 19
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 17
- OPXKTCUYRHXSBK-UHFFFAOYSA-N clenbuterol hydrochloride Chemical compound Cl.CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 OPXKTCUYRHXSBK-UHFFFAOYSA-N 0.000 description 16
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 14
- 229930182555 Penicillin Natural products 0.000 description 12
- 229940049954 penicillin Drugs 0.000 description 12
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 11
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 10
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 10
- 230000035945 sensitivity Effects 0.000 description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 description 8
- 235000019371 penicillin G benzathine Nutrition 0.000 description 8
- 229940056360 penicillin g Drugs 0.000 description 8
- 239000008363 phosphate buffer Substances 0.000 description 8
- 239000012064 sodium phosphate buffer Substances 0.000 description 8
- 244000309466 calf Species 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 229920005654 Sephadex Polymers 0.000 description 6
- 239000012507 Sephadex™ Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000003018 immunoassay Methods 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 210000004400 mucous membrane Anatomy 0.000 description 6
- 108010008488 Glycylglycine Proteins 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 229940043257 glycylglycine Drugs 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 229940107700 pyruvic acid Drugs 0.000 description 5
- GFFIJCYHQYHUHB-UHFFFAOYSA-N 2-acetylsulfanylethyl(trimethyl)azanium Chemical compound CC(=O)SCC[N+](C)(C)C GFFIJCYHQYHUHB-UHFFFAOYSA-N 0.000 description 4
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 4
- 102000012440 Acetylcholinesterase Human genes 0.000 description 4
- 108010022752 Acetylcholinesterase Proteins 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 238000007405 data analysis Methods 0.000 description 4
- 238000001952 enzyme assay Methods 0.000 description 4
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 150000008195 galaktosides Chemical class 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- ZSAZGCBSZUURAX-UHFFFAOYSA-N 1-chloro-4-(diethoxyphosphorylsulfanylmethylsulfanyl)benzene Chemical compound CCOP(=O)(OCC)SCSC1=CC=C(Cl)C=C1 ZSAZGCBSZUURAX-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102100024074 Dystrobrevin alpha Human genes 0.000 description 2
- 102000002464 Galactosidases Human genes 0.000 description 2
- 108010093031 Galactosidases Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 101001053689 Homo sapiens Dystrobrevin alpha Proteins 0.000 description 2
- 101000574396 Homo sapiens Protein phosphatase 1K, mitochondrial Proteins 0.000 description 2
- 102100025799 Protein phosphatase 1K, mitochondrial Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229940022698 acetylcholinesterase Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000009514 concussion Effects 0.000 description 2
- PYRZPBDTPRQYKG-UHFFFAOYSA-N cyclopentene-1-carboxylic acid Chemical compound OC(=O)C1=CCCC1 PYRZPBDTPRQYKG-UHFFFAOYSA-N 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 150000004345 1,2-dihydroxyanthraquinones Chemical class 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- RGCKGOZRHPZPFP-UHFFFAOYSA-N Alizarin Natural products C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241001212149 Cathetus Species 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 1
- 101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010033647 Pancreatitis acute Diseases 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 102000005488 Thioesterase Human genes 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 201000003229 acute pancreatitis Diseases 0.000 description 1
- HFVAFDPGUJEFBQ-UHFFFAOYSA-M alizarin red S Chemical compound [Na+].O=C1C2=CC=CC=C2C(=O)C2=C1C=C(S([O-])(=O)=O)C(O)=C2O HFVAFDPGUJEFBQ-UHFFFAOYSA-M 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000006957 competitive inhibition Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940111205 diastase Drugs 0.000 description 1
- RAABOESOVLLHRU-UHFFFAOYSA-N diazene Chemical compound N=N RAABOESOVLLHRU-UHFFFAOYSA-N 0.000 description 1
- 229910000071 diazene Inorganic materials 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000002952 image-based readout Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 150000004780 naphthols Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 238000011057 process analytical technology Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229960001866 silicon dioxide Drugs 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 108020002982 thioesterase Proteins 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical class [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/27—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
- G01N21/272—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration for following a reaction, e.g. for determining photometrically a reaction rate (photometric cinetic analysis)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2334/00—O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N2021/3125—Measuring the absorption by excited molecules
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/33—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using ultraviolet light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/904—Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/91045—Acyltransferases (2.3)
- G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
- G01N2333/938—Hydrolases (3) acting on glycosyl compounds (3.2) acting on beta-galactose-glycoside bonds, e.g. beta-galactosidase
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mathematical Physics (AREA)
- Theoretical Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
Claims (9)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210355606.8A CN102879343B (zh) | 2012-09-21 | 2012-09-21 | 用多波长吸收单通道同步测量多种酶活性的方法 |
US14/430,391 US9611502B2 (en) | 2012-09-21 | 2012-09-24 | Method for simultaneously measuring activity of various enzymes by using multi-wavelength absorption single channel |
PCT/CN2012/081869 WO2014043923A1 (zh) | 2012-09-21 | 2012-09-24 | 用多波长吸收单通道同步测量多种酶活性的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210355606.8A CN102879343B (zh) | 2012-09-21 | 2012-09-21 | 用多波长吸收单通道同步测量多种酶活性的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102879343A CN102879343A (zh) | 2013-01-16 |
CN102879343B true CN102879343B (zh) | 2014-10-29 |
Family
ID=47480751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210355606.8A Active CN102879343B (zh) | 2012-09-21 | 2012-09-21 | 用多波长吸收单通道同步测量多种酶活性的方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US9611502B2 (zh) |
CN (1) | CN102879343B (zh) |
WO (1) | WO2014043923A1 (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102879343B (zh) | 2012-09-21 | 2014-10-29 | 重庆医科大学 | 用多波长吸收单通道同步测量多种酶活性的方法 |
CN106644970A (zh) * | 2016-09-30 | 2017-05-10 | 华南理工大学 | 一种利用紫外‑可见分光光度法同时测定溶液中亚甲基蓝和二价铜离子的三波长光谱方法 |
CN107515633B (zh) * | 2017-09-07 | 2020-04-21 | 长沙理工大学 | 一种单酶法生产海藻糖的监控方法 |
CN109576343A (zh) * | 2018-12-29 | 2019-04-05 | 重庆博蓝鹰生物技术有限公司 | 一种连续法测定酸性磷酸酶活性试剂盒的配方 |
KR20220066161A (ko) * | 2019-10-01 | 2022-05-23 | 리플리겐 코포레이션 | 유체의 단백질 농도 측정 |
CN110702623B (zh) * | 2019-10-25 | 2022-02-15 | 徐詹程 | 一种酶促反应底物浓度检测方法 |
CN114112953B (zh) * | 2021-11-19 | 2023-08-22 | 厦门大学 | 一种基于光度检测的湿化学微型原位传感器及其测定方法 |
CN114184562A (zh) * | 2021-11-19 | 2022-03-15 | 北京赛升药业股份有限公司 | 一种发色底物法测定尿激酶活性的方法 |
CN116793976B (zh) * | 2023-06-29 | 2024-05-10 | 徐詹程 | 一种酶促反应分析底物浓度拟合标准曲线的方法 |
CN116735511B (zh) * | 2023-06-29 | 2024-05-31 | 徐詹程 | 一种酶促反应分析酶浓度拟合标准曲线的方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI901680A0 (fi) * | 1989-04-10 | 1990-04-03 | Univ Georgia | Enzymluminescensanalys. |
US6927037B2 (en) * | 2000-06-22 | 2005-08-09 | Pharmacia Corporation | Ion-exchange resin/enzyme activity assay |
WO2004063339A2 (en) | 2003-01-08 | 2004-07-29 | Lesley Davenport | G-quadruplex binding assays and compounds therefor |
US20060003383A1 (en) * | 2004-06-07 | 2006-01-05 | Applera Corporation | Fluorogenic enzyme activity assay methods and compositions using fragmentable linkers |
CN100489496C (zh) * | 2004-06-07 | 2009-05-20 | 中国科学技术大学 | 污泥脱氢酶活性测定方法 |
CN1786185A (zh) | 2004-12-10 | 2006-06-14 | 苏州艾杰生物科技有限公司 | 血管紧张素转换酶活性测定方法及血管紧张素转换酶诊断试剂盒 |
EP1724359A1 (en) | 2005-05-18 | 2006-11-22 | PerkinElmer Life and Analytical Sciences B.V. | Luciferase assay system |
CN102507470B (zh) * | 2011-10-20 | 2014-09-24 | 重庆医科大学 | 联用酶反应过程分析法和终点平衡法测定酶底物量的方法 |
CN102533937A (zh) | 2012-02-03 | 2012-07-04 | 苏州大学附属第一医院 | 一种检测adamts13酶活性的荧光底物及检测方法 |
CN102879343B (zh) | 2012-09-21 | 2014-10-29 | 重庆医科大学 | 用多波长吸收单通道同步测量多种酶活性的方法 |
-
2012
- 2012-09-21 CN CN201210355606.8A patent/CN102879343B/zh active Active
- 2012-09-24 US US14/430,391 patent/US9611502B2/en active Active
- 2012-09-24 WO PCT/CN2012/081869 patent/WO2014043923A1/zh active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CN102879343A (zh) | 2013-01-16 |
WO2014043923A1 (zh) | 2014-03-27 |
US20150225764A1 (en) | 2015-08-13 |
US9611502B2 (en) | 2017-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102879343B (zh) | 用多波长吸收单通道同步测量多种酶活性的方法 | |
Bradner et al. | Chemical phylogenetics of histone deacetylases | |
Yamada et al. | Biochemical evidence for the involvement of tyrosine in epoxide activation during the catalytic cycle of epoxide hydrolase | |
Morisseau et al. | Measurement of soluble epoxide hydrolase (sEH) activity | |
Kreuzer et al. | Novel electrochemical immunosensors for seafood toxin analysis | |
Marsolais et al. | Identification of Amino Acid Residues Critical for Catalysis and Cosubstrate Binding in the Flavonol 3-Sulfotransferase (∗) | |
Holas et al. | The progress in the cholinesterase quantification methods | |
Allen et al. | Bio-orthogonal affinity purification of direct kinase substrates | |
Vilariño et al. | Biological methods for marine toxin detection | |
Campàs et al. | Towards the protein phosphatase-based biosensor for microcystin detection | |
Dong et al. | Inhibitory effects of ionic liquids on the lactic dehydrogenase activity | |
Renner et al. | Determination of mycophenolic acid and mycophenolate mofetil by high-performance liquid chromatography using postcolumn derivatization | |
Rodriguez et al. | Solid-phase receptor-based assay for the detection of cyclic imines by chemiluminescence, fluorescence, or colorimetry | |
Eser et al. | Measurement of intrinsic rate constants in the tyrosine hydroxylase reaction | |
Botana et al. | Functional assays for marine toxins as an alternative, high-throughput-screening solution to animal tests | |
Soldatkin et al. | Development of potentiometric creatinine-sensitive biosensor based on ISFET and creatinine deiminase immobilised in PVA/SbQ photopolymeric membrane | |
Gong et al. | Aspartate-279 in aminolevulinate synthase affects enzyme catalysis through enhancing the function of the pyridoxal 5 ‘-phosphate cofactor | |
Wu et al. | Evaluation of xanthine oxidase inhibitory activity of flavonoids by an online capillary electrophoresis‐based immobilized enzyme microreactor | |
Zhang et al. | Evaluation inhibitory activity of catechins on trypsin by capillary electrophoresis–based immobilized enzyme microreactor with chromogenic substrate | |
Alhazmi et al. | Application of drug–metal ion interaction principle in conductometric determination of imatinib, sorafenib, gefitinib and bosutinib | |
Wang et al. | Rapid screening of aminopeptidase N inhibitors by capillary electrophoresis with electrophoretically mediated microanalysis | |
Migaud et al. | Probing Aplysia californica Adenosine 5 ‘-Diphosphate Ribosyl Cyclase for Substrate Binding Requirements: Design of Potent Inhibitors | |
Bateson et al. | Single Copies of Subunits d, Oligomycin-sensitivity Conferring Protein, and b Are Present in the Saccharomyces cerevisiaeMitochondrial ATP Synthase | |
Menden et al. | A fast, miniaturised in-vitro assay developed for quantification of lipase enzyme activity | |
Hua et al. | Fe2+-Catalyzed Oxidation and Cleavage of Sarcoplasmic Reticulum ATPase Reveals Mg2+ and Mg2+− ATP Sites |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200515 Address after: 401332 2nd Floor, Building 3, Innovative Productivity Promotion Center, Xiyong Micropower Park, Shapingba District, Chongqing Patentee after: CHONGQING BOLANYING (BLY) BIOTECHNOLOGY Co.,Ltd. Address before: 400016 No. 1, Medical College Road, Yuzhong District, Chongqing Patentee before: Chongqing Medical University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220208 Address after: 401332 room 206, building 3, Innovation Productivity Promotion Center, Xiyong micro power park, Shapingba District, Chongqing Patentee after: Chongqing Fulai shark Biotechnology Co.,Ltd. Address before: 401332 floor 2, building 3, innovation and Productivity Promotion Center, Xiyong micro electric park, Shapingba District, Chongqing Patentee before: CHONGQING FARSIGHTED BLUE DRAGON (FBD) BIOTECHNOLOGY Co.,Ltd. CHINA |